[Type 4a myocardial infarction]

Area of Science:

• Cardiology
• Biochemistry

Context:

• Percutaneous coronary interventions (PCI) are common procedures for coronary artery disease.
• Post-PCI cardiac biomarker elevation is a recognized phenomenon.

Purpose:

• To review the clinical and prognostic implications of type 4a myocardial infarction (MI).
• To discuss the significance of biomarker elevation after uncomplicated PCI.

Summary:

• Type 4a MI is defined by elevated cardiac troponins and creatine kinase MB post-PCI.
• This elevation can occur despite angiographically and clinically uncomplicated procedures.
• Understanding type 4a MI is crucial for accurate patient assessment.

Impact:

• Provides insights into the clinical management of patients experiencing biomarker elevation after PCI.
• Highlights the prognostic relevance of type 4a MI.
• Aids clinicians in interpreting cardiac biomarker changes in the post-PCI setting.